Real-world adherence, persistence, and in-class switching during use of dipeptidyl peptidase-4 inhibitors: a systematic review and meta-analysis involving 594,138 patients with type 2 diabetes
Oyepeju Ogundipe, Mohsen Mazidi, Ken Lee Chin, Deval Gor, Andrew McGovern, Berhe W. Sahle, György Jermendy, Maarit Jaana Korhonen, Bernard Appiah, Zanfina Ademi, Marie L. De Bruin, Danny Liew, Richard Ofori‐Asenso
Topics & Concepts
MedicineAlogliptinSaxagliptinMeta-analysisType 2 diabetesInternal medicineDrug classOdds ratioConfidence intervalDipeptidyl peptidase-4 inhibitorCochrane LibraryPersistence (discontinuity)Observational studyDipeptidyl peptidase-4Diabetes mellitusPharmacologyEndocrinologyDrugSitagliptinEngineeringGeotechnical engineeringDiabetes Treatment and ManagementMedication Adherence and ComplianceHeart Failure Treatment and Management